CIC reduces xCT/SLC7A11 expression and glutamate release in glioma
Open Access
- 16 January 2023
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 11 (1) , 1-12
Abstract
Capicua (CIC) is an important downstream molecule of RTK/RAS/MAPK pathway. The regulatory mechanism of CIC underlying tumorigenesis in oligodendroglioma, where CIC is frequently mutated, has yet to be fully elucidated. Using patient-derived glioma lines, RNA-sequencing and bioinformatic analysis of publicly available databases, we investigated how CIC loss- or gain-of-function regulates its downstream targets, cell proliferation and glutamate release. Our results indicate an increased frequency of CIC truncating mutations in oligodendroglioma during progression. In vitro, CIC modulation had a modest effect on cell proliferation in glioma lines, and no significant changes in the expression of ETV1, ETV4 and ETV5. Transcriptional repression of known CIC targets was observed in gliomas expressing non-phosphorylatable CIC variant on Ser173 which was unable to interact with 14-3-3. These data outline a mechanism by which the repressor function of CIC is inhibited by 14-3-3 in gliomas. Using transcriptional profiling, we found that genes related to glutamate release were upregulated because of CIC depletion. In addition, loss of CIC leads to increased extracellular glutamate. Consistent with this, CIC restoration in an oligodendroglioma line reduced the levels of extracellular glutamate, neuronal toxicity and xCT/SLC7A11 expression. Our findings may provide a molecular basis for the prevention of glioma-associated seizures.Keywords
Funding Information
- Fritz Thyssen Stiftung
- Oligo Nation and Operation Oligo Cure
- Deutsche Krebshilfe (70111964)
- Universitätsklinikum Heidelberg
This publication has 36 references indexed in Scilit:
- Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumorsLaboratory Investigation, 2014
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The Capicua repressor – a general sensor of RTK signaling in development and diseaseJournal of Cell Science, 2012
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Mutations in CIC and FUBP1 Contribute to Human OligodendrogliomaScience, 2011
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancersThe Journal of Pathology, 2011
- ERK/p90RSK/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúaBiochemical Journal, 2011
- Capicua Regulates Cell Proliferation Downstream of the Receptor Tyrosine Kinase/Ras Signaling PathwayCurrent Biology, 2007
- 2‐DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM)Proteomics, 2006
- Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding ProteinsJournal of Biological Chemistry, 2004